nitrobenzylthioinosine 5'-monophosphate has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frandsen, JL; McIvor, RS; Sweeney, CL; Verfaillie, CM | 1 |
Cha, S; Diop, D; el Kouni, MH | 1 |
2 other study(ies) available for nitrobenzylthioinosine 5'-monophosphate and Disease Models, Animal
Article | Year |
---|---|
Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Drug Synergism; Female; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred C3H; Mice, Transgenic; Tetrahydrofolate Dehydrogenase; Thioinosine; Thionucleotides; Trimetrexate | 2003 |
Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate.
Topics: Animals; Biological Transport; Disease Models, Animal; Drug Therapy, Combination; Female; Inosine; Mice; Ribonucleosides; Schistosomiasis; Thioinosine; Thionucleotides; Tubercidin | 1983 |